LeadIQ logo
Learn more at LeadIQ.com

Insights

Clinical-Stage Novel Radiopharmaceuticals Precirix focuses on developing targeted radiopharmaceuticals for cancer patients using innovative camelid single domain antibody fragments, presenting a unique opportunity for collaboration and partnerships in the oncology sector.

Theranostic Approach for Precision Medicine With a technology platform enabling a theranostic approach that combines imaging and therapy using the same molecule, Precirix offers a cutting-edge solution that aligns with the growing trend towards precision medicine, creating potential sales avenues for personalized cancer treatment.

Expanding Pipeline and Clinical Trials As the company advances its lead product CAM-H2 through Phase I/II clinical trials and expands its oncology pipeline, there are openings for partnerships with organizations interested in collaborating on clinical research and product development in the biotechnology research field.

Strong Financial Backing and Revenue Generation With substantial funding of $88M and revenue in the range of $0-10M, Precirix showcases financial stability and growth potential, making it an attractive opportunity for investors, biotech companies, and healthcare institutions looking to engage in strategic investments or acquisitions.

Competitive Landscape Analysis By comparing Precirix to similar companies like OncoResponse, Acticor Biotech, Indapta Therapeutics, Treeway, and Nanobiotix, there is a chance to identify competitive advantages, market positioning strategies, and potential areas for differentiation to capitalize on distinctive offerings in the biotechnology research market.

Similar companies to Precirix

Precirix Tech Stack

Precirix uses 8 technology products and services including Craft CMS, SAP, React, and more. Explore Precirix's tech stack below.

  • Craft CMS
    Content Management System
  • SAP
    Customer Relationship Management
  • React
    Javascript Frameworks
  • Open Graph
    Miscellaneous
  • PWA
    Miscellaneous
  • PHP
    Programming Languages
  • HSTS
    Security
  • Google Tag Manager
    Tag Management

Media & News

Precirix's Email Address Formats

Precirix uses at least 2 format(s):
Precirix Email FormatsExamplePercentage
First.Last@camel-ids.comJohn.Doe@camel-ids.com
92%
First.Middle.Last@camel-ids.comJohn.Michael.Doe@camel-ids.com
8%
First.Last@precirix.comJohn.Doe@precirix.com
71%
Last@precirix.comDoe@precirix.com
29%

Frequently Asked Questions

Where is Precirix's headquarters located?

Minus sign iconPlus sign icon
Precirix's main headquarters is located at Burgemeester Etienne Demunterlaan 1 Brussels, 1090 BE. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Precirix's official website and social media links?

Minus sign iconPlus sign icon
Precirix's official website is precirix.com and has social profiles on LinkedIn.

How much revenue does Precirix generate?

Minus sign iconPlus sign icon
As of May 2024, Precirix's annual revenue reached $7.5M.

What is Precirix's SIC code NAICS code?

Minus sign iconPlus sign icon
Precirix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Precirix have currently?

Minus sign iconPlus sign icon
As of May 2024, Precirix has approximately 42 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Technology Officer: D. M.Chief Operating Officer: J. G.Head Of Alliance And Program Management: J. D. V.. Explore Precirix's employee directory with LeadIQ.

What industry does Precirix belong to?

Minus sign iconPlus sign icon
Precirix operates in the Biotechnology Research industry.

What technology does Precirix use?

Minus sign iconPlus sign icon
Precirix's tech stack includes Craft CMSSAPReactOpen GraphPWAPHPHSTSGoogle Tag Manager.

What is Precirix's email format?

Minus sign iconPlus sign icon
Precirix's email format typically follows the pattern of . Find more Precirix email formats with LeadIQ.

How much funding has Precirix raised to date?

Minus sign iconPlus sign icon
As of May 2024, Precirix has raised $88M in funding. The last funding round occurred on Mar 16, 2022 for $88M.

When was Precirix founded?

Minus sign iconPlus sign icon
Precirix was founded in 2014.
Precirix

Precirix

Biotechnology ResearchBrussels, Belgium11-50 Employees

PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting HER2-positive tumors, while further progressing and broadening its oncology pipeline.

PRECIRIX' technology platform allows for a theranostic approach, using the same molecule for patient selection (imaging) and therapy.

Section iconCompany Overview

Headquarters
Burgemeester Etienne Demunterlaan 1 Brussels, 1090 BE
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $88M

    Precirix has raised a total of $88M of funding over 2 rounds. Their latest funding round was raised on Mar 16, 2022 in the amount of $88M.

  • $10M

    Precirix's revenue is in the range of $10M

Section iconFunding & Financials

  • $88M

    Precirix has raised a total of $88M of funding over 2 rounds. Their latest funding round was raised on Mar 16, 2022 in the amount of $88M.

  • $10M

    Precirix's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.